NCT04181203
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04181203
Title Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy (CARLHA-2)
Acronym CARLHA-2
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Clinique Claude Bernard Albi France Details
Institut de Cancérologie de l'Ouest Angers France Details
Institut Bergonié Bordeau France Details
Centre Georges François LECLERC Dijon France Details
Centre Hospitalier Emile ROUX Le Puy-en-Velay France Details
Centre Oscar Lambret Lille France Details
Institut de Cancérologie de Montpellier Montpellier France Details
Centre Antoine Lacassagne Nice France Details
Institut Jean Godinot Reims France Details
Centre Henri Becquerel Rouen France Details
Institut de Cancérologie de l'Ouest Saint-Herblain France Details
Institut de Cancérologie de la Loire Lucien Neuwirth Saint-Priest-en-Jarez France Details
Institut de Cancérologie Paris Nord Sarcelles France Details
Centre Paul STRAUSS Strasbourg France Details
Clinique Pasteur - ONCORAD Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field